Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiya Inada

Showing results (41-50 of 242) with videos related to

Pageof 25
Sort By:
Biological Psychiatry|June 29, 2004
Association between chromogranin b gene polymorphisms and schizophrenia in the Japanese populationYoshimi Iijima, Toshiya Inada, Tsuyuka Ohtsuki, et al.
Human Psychopharmacology|June 17, 2011
The inter-rater reliability of the Japanese version of the Inventory of Depressive Symptomatology, clinician versionNobutomo Yamamoto, Sachiko Kawakami, Koichi Sato, et al.
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|November 4, 2015
[Individually Safe and Realistic Correction of Antipsychotic Polypharmacy and High-dose Regimens in Japanese Patients with Chronic Schizophrenia: The SCAP method]Yoshio Yamanouchi, Tsuruhei Sukegawa, Ataru Inagaki, et al.
Journal of Human Genetics|July 8, 2008
No association between the oligodendrocyte-related gene PLP1 and schizophrenia in the Japanese populationBranko Aleksic, Masashi Ikeda, Ryoko Ishihara, et al.
Scientific Reports|August 16, 2017
Drug-induced Extrapyramidal Symptoms Scale (DIEPSS) Serbian Language version: Inter-rater and Test-retest ReliabilityAmi Peljto, Ljubica Zamurovic, Milica Pejovic Milovancevic, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|March 1, 2021
Significant decrease in delirium referrals after changing hypnotic from benzodiazepine to suvorexantMasako Tachibana, Toshiya Inada, Masaru Ichida, et al.
The International Journal of Neuropsychopharmacology|December 19, 2014
Evaluation of the individual safe correction of antipsychotic agent polypharmacy in Japanese patients with chronic schizophrenia: validation of safe corrections for antipsychotic polypharmacy and the high-dose methodYoshio Yamanouchi, Tsuruhei Sukegawa, Ataru Inagaki, et al.
Neuropsychopharmacology Reports|April 29, 2023
Clinical characterization of patients with schizophrenia and 16p13.11 duplication: A case seriesHiroki Kimura, Itaru Kushima, Masahiro Banno, et al.
BMC Medical Research Methodology|April 30, 2002
Are the cochrane group registers comprehensive? A case study of Japanese psychiatry trialsToshi A Furukawa, Toshiya Inada, Clive E Adams, et al.
BMC Psychiatry|April 9, 2014
Study protocol: safety correction of high dose antipsychotic polypharmacy in JapanTsuruhei Sukegawa, Ataru Inagaki, Yoshio Yamanouchi, et al.
Pageof 25

Showing results (41-50 of 242) with videos related to

Sort By:
Pageof 25
Biological Psychiatry|June 29, 2004
Association between chromogranin b gene polymorphisms and schizophrenia in the Japanese populationYoshimi Iijima, Toshiya Inada, Tsuyuka Ohtsuki, et al.
Human Psychopharmacology|June 17, 2011
The inter-rater reliability of the Japanese version of the Inventory of Depressive Symptomatology, clinician versionNobutomo Yamamoto, Sachiko Kawakami, Koichi Sato, et al.
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|November 4, 2015
[Individually Safe and Realistic Correction of Antipsychotic Polypharmacy and High-dose Regimens in Japanese Patients with Chronic Schizophrenia: The SCAP method]Yoshio Yamanouchi, Tsuruhei Sukegawa, Ataru Inagaki, et al.
Journal of Human Genetics|July 8, 2008
No association between the oligodendrocyte-related gene PLP1 and schizophrenia in the Japanese populationBranko Aleksic, Masashi Ikeda, Ryoko Ishihara, et al.
Scientific Reports|August 16, 2017
Drug-induced Extrapyramidal Symptoms Scale (DIEPSS) Serbian Language version: Inter-rater and Test-retest ReliabilityAmi Peljto, Ljubica Zamurovic, Milica Pejovic Milovancevic, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|March 1, 2021
Significant decrease in delirium referrals after changing hypnotic from benzodiazepine to suvorexantMasako Tachibana, Toshiya Inada, Masaru Ichida, et al.
The International Journal of Neuropsychopharmacology|December 19, 2014
Evaluation of the individual safe correction of antipsychotic agent polypharmacy in Japanese patients with chronic schizophrenia: validation of safe corrections for antipsychotic polypharmacy and the high-dose methodYoshio Yamanouchi, Tsuruhei Sukegawa, Ataru Inagaki, et al.
Neuropsychopharmacology Reports|April 29, 2023
Clinical characterization of patients with schizophrenia and 16p13.11 duplication: A case seriesHiroki Kimura, Itaru Kushima, Masahiro Banno, et al.
BMC Medical Research Methodology|April 30, 2002
Are the cochrane group registers comprehensive? A case study of Japanese psychiatry trialsToshi A Furukawa, Toshiya Inada, Clive E Adams, et al.
BMC Psychiatry|April 9, 2014
Study protocol: safety correction of high dose antipsychotic polypharmacy in JapanTsuruhei Sukegawa, Ataru Inagaki, Yoshio Yamanouchi, et al.
Pageof 25